{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:01:51Z","timestamp":1787162511371,"version":"build-2736575974"},"reference-count":90,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) represents approximately 5% of Hodgkin lymphoma and typically affects children and young adults. Although the overall prognosis is favorable, variant growth patterns in NLPHL correlate with disease recurrence and progression to T-cell\/histiocyte-rich large B-cell lymphoma or frank diffuse large B-cell lymphoma (DLBCL). The diagnostic boundary between NLPHL and DLBCL can be difficult to discern, especially in the presence of variant histologies. Both diagnoses are established using morphology and immunophenotype and share similarities, including the infrequent large tumor B-cells and the lymphocyte and histiocyte-rich microenvironment. NLPHL also shows overlap with other lymphomas, particularly, classic Hodgkin lymphoma and T-cell lymphomas. Similarly, there is overlap with non-neoplastic conditions, such as the progressive transformation of germinal centers. Given the significant clinical differences among these entities, it is imperative that NLPHL and its variants are carefully separated from other lymphomas and their mimics. In this article, the characteristic features of NLPHL and its diagnostic boundaries and pitfalls are discussed. The current understanding of genetic features and immune microenvironment will be addressed, such that a framework to better understand biological behavior and customize patient care is provided.<\/jats:p>","DOI":"10.3390\/cancers13123021","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T10:27:07Z","timestamp":1623839227000},"page":"3021","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Pitfalls in the Diagnosis of Nodular Lymphocyte Predominant Hodgkin Lymphoma: Variant Patterns, Borderlines and Mimics"],"prefix":"10.3390","volume":"13","author":[{"given":"Sheren","family":"Younes","sequence":"first","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca B.","family":"Rojansky","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4499-1104","authenticated-orcid":false,"given":"Joshua R.","family":"Menke","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9182-8123","authenticated-orcid":false,"given":"Dita","family":"Gratzinger","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-1018","authenticated-orcid":false,"given":"Yasodha","family":"Natkunam","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00390466","article-title":"Clinical features of nodular paragranuloma (Hodgkin\u2019s disease, lymphocyte predominance type, nodular)","volume":"108","author":"Hansmann","year":"1984","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3322\/caac.21357","article-title":"2016 US lymphoid malignancy statistics by World Health Organization subtypes","volume":"66","author":"Teras","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","unstructured":"Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., and Thiele, J. (2017). Nodular lymphocyte predominant Hodgkin lymphoma. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1200\/JCO.2015.65.3469","article-title":"Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children\u2019s Oncology Group","volume":"34","author":"Appel","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/bjh.14518","article-title":"Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: Clinical characteristics and treatment outcome\u2014A report from the SFCE & CCLG groups","volume":"177","author":"Shankar","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/asheducation-2017.1.324","article-title":"Nodular lymphocyte-predominant Hodgkin lymphoma: A unique disease deserving unique management","volume":"2017","author":"Eichenauer","year":"2017","journal-title":"Hematology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e27375","DOI":"10.1002\/pbc.27375","article-title":"Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children\u2019s Oncology Group","volume":"65","author":"Marks","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1182\/blood.2019003877","article-title":"Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: A multi-institutional study of adult patients by ILROG","volume":"135","author":"Binkley","year":"2020","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.6004\/jnccn.2020.0026","article-title":"Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Hoppe","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1200\/JCO.2014.60.4363","article-title":"Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group","volume":"33","author":"Eichenauer","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1200\/JCO.19.00986","article-title":"Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group","volume":"38","author":"Eichenauer","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0046-8177(89)80007-3","article-title":"Nodular paragranuloma can transform into high-grade malignant lymphoma of B type","volume":"20","author":"Hansmann","year":"1989","journal-title":"Hum. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM198801283180404","article-title":"Nodular and Diffuse Types of Lymphocyte Predominance Hodgkin\u2019s Disease","volume":"318","author":"Regula","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_15","first-page":"29","article-title":"Diffuse lymphocyte-predominant Hodgkin\u2019s disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type","volume":"138","author":"Hansmann","year":"1991","journal-title":"Am. J. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1182\/blood-2003-02-0626","article-title":"Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell\/histiocyte-rich B-cell lymphoma: Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell\/histiocyte-rich B-cell lymphoma","volume":"102","author":"Torlakovic","year":"2003","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/13.S1.44","article-title":"Workshop on the relationship between nodular lymphocyte predominant Hodgkin\u2019s lymphoma and T cell\/histiocyte-rich B cell lymphoma","volume":"13","author":"Gascoyne","year":"2002","journal-title":"Ann. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1080\/10428190701559124","article-title":"T-cell\/histiocyte-rich B-cell lymphoma: Clinical presentation, management and prognostic factors: Report on 61 patients and review of literature","volume":"48","author":"Akhtar","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Hartmann, S., D\u00f6ring, C., Jakobus, C., Rengstl, B., Newrzela, S., Tousseyn, T., Sagaert, X., Ponzoni, M., Facchetti, F., and De Wolf-Peeters, C. (2013). Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell\/Histiocyte Rich Large B Cell Lymphoma\u2014Endpoints of a Spectrum of One Disease?. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0078812"},{"key":"ref_20","unstructured":"Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., and Thiele, J. (2017). T-cell\/histiocyte-rich large B-cell lymphoma. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press."},{"key":"ref_21","first-page":"1269","article-title":"T-Cell\/Histiocyte\u2013Rich Large B-Cell Lymphoma: A Distinct Clinicopathologic Entity","volume":"20","author":"Achten","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1200\/JCO.2003.06.046","article-title":"T-Cell\/Histiocyte-Rich Large B-Cell Lymphomas and Classical Diffuse Large B-Cell Lymphomas Have Similar Outcome After Chemotherapy: A Matched-Control Analysis","volume":"21","author":"Bouabdallah","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.24819","article-title":"Nodular, lymphocyte-predominant Hodgkin lymphoma","volume":"116","author":"Biasoli","year":"2009","journal-title":"Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1200\/JCO.2009.24.9516","article-title":"Transformation to Aggressive Lymphoma in Nodular Lymphocyte-Predominant Hodgkin\u2019s Lymphoma","volume":"28","author":"Connors","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1002\/ajh.23989","article-title":"Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant hodgkin lymphoma: Long-term outcomes from a 30-year experience","volume":"90","author":"Eyre","year":"2015","journal-title":"Am. J. Hematol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1182\/blood-2015-08-665505","article-title":"Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution","volume":"127","author":"Kenderian","year":"2016","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","article-title":"Characterization of Variant Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma with Immunohistologic and Clinical Correlation","volume":"27","author":"Fan","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","article-title":"The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group (GHSG)","volume":"122","author":"Hartmann","year":"2013","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/ajh.25607","article-title":"The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma","volume":"94","author":"Hartmann","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bjh.13540","article-title":"Childhood and Adolescent nodular lymphocyte predominant Hodgkin lymphoma\u2014A review of clinical outcome based on the histological variants","volume":"171","author":"Shankar","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199708143370703","article-title":"Origin of Nodular Lymphocyte-Predominant Hodgkin\u2019s Disease from a Clonal Expansion of Highly Mutated Germinal-Center B Cells","volume":"337","author":"Marafioti","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5858\/arpa.2020-0135-OA","article-title":"CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center","volume":"145","author":"Menke","year":"2021","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12308-011-0104-x","article-title":"Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with CD30-positive lymphocyte-predominant (LP) cells","volume":"4","author":"Seliem","year":"2011","journal-title":"J. Hematop."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2559.2011.03829.x","article-title":"CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma","volume":"58","author":"Venkataraman","year":"2011","journal-title":"Histopathology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/modpathol.2009.54","article-title":"Lymphocyte-rich classical Hodgkin\u2019s lymphoma: Distinctive tumor and microenvironment markers","volume":"22","author":"Salcedo","year":"2009","journal-title":"Mod. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12308-009-0053-9","article-title":"Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France","volume":"2","author":"Hsi","year":"2009","journal-title":"J. Hematop."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood.V97.2.496","article-title":"Down-regulation of BOB.1\/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription","volume":"97","author":"Stein","year":"2001","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2017.08.015","article-title":"J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"68","author":"Moore","year":"2017","journal-title":"Hum. Pathol."},{"key":"ref_39","first-page":"834","article-title":"Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities","volume":"33","author":"Huh","year":"2019","journal-title":"Mod. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.pas.0000194741.87798.45","article-title":"IgD Positive L&H Cells Identify a Unique Subset of Nodular Lymphocyte Predominant Hodgkin Lymphoma","volume":"30","author":"Prakash","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e26753","DOI":"10.1002\/pbc.26753","article-title":"Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: A report from the Children\u2019s Oncology Group","volume":"65","author":"Untanu","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1038\/s41467-020-16375-6","article-title":"Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma","volume":"11","author":"Thurner","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0002-9440(10)64462-8","article-title":"Comparative Genomic Hybridization Pattern Distinguishes T-Cell\/Histiocyte-Rich B-Cell Lymphoma from Nodular Lymphocyte Predominance Hodgkin\u2019s Lymphoma","volume":"161","author":"Franke","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood-2002-05-1592","article-title":"Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma","volume":"101","author":"Wlodarska","year":"2003","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.humpath.2010.05.010","article-title":"Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: Comparison with CD57 and lymphomas in the differential diagnosis","volume":"41","author":"Churchill","year":"2010","journal-title":"Hum. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/PAS.0b013e318165b0d6","article-title":"PD-1, a Follicular T-cell Marker Useful for Recognizing Nodular Lymphocyte-predominant Hodgkin Lymphoma","volume":"32","author":"Roncador","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.humpath.2017.10.029","article-title":"Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes","volume":"71","author":"Panjwani","year":"2018","journal-title":"Hum. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/PAS.0000000000000107","article-title":"EBV May Be Expressed in the LP Cells of Nodular Lymphocyte\u2013predominant Hodgkin Lymphoma (NLPHL) in Both Children and Adults","volume":"38","author":"Huppmann","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.anndiagpath.2014.03.007","article-title":"Epstein-Barr virus\u2013positive nodular lymphocyte predominant Hodgkin lymphoma","volume":"18","author":"Wang","year":"2014","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00428-018-2460-8","article-title":"A high number of IgG4-positive plasma cells rules out nodular lymphocyte predominant Hodgkin lymphoma","volume":"473","author":"Kiil","year":"2018","journal-title":"Virchows Arch."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ajpath.2016.10.007","article-title":"Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting","volume":"187","author":"Fromm","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1525-1578(10)60564-8","article-title":"Molecular Cytogenetic Analyses of Immunoglobulin Loci in Nodular Lymphocyte Predominant Hodgkin\u2019s Lymphoma Reveal a Recurrent IGH-BCL6 Juxtaposition","volume":"7","author":"Hansmann","year":"2005","journal-title":"J. Mol. Diagn."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1309\/Y8KD32QGRYFN1XQX","article-title":"A Double-Positive CD4+CD8+ T-Cell Population Is Commonly Found in Nodular Lymphocyte Predominant Hodgkin Lymphoma","volume":"126","author":"Rahemtullah","year":"2006","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/leu.2015.328","article-title":"Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma","volume":"30","author":"Hartmann","year":"2015","journal-title":"Leukemia"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1084\/jem.20080809","article-title":"Origin and pathogenesis of nodular lymphocyte\u2013predominant Hodgkin lymphoma as revealed by global gene expression analysis","volume":"205","author":"Brune","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_57","first-page":"440","article-title":"T-cell\/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response","volume":"95","author":"Tousseyn","year":"2009","journal-title":"Haematology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/pin.12357","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma: Clincopathological study of 25 cases from Japan with a reappraisal of tissue associated macrophages","volume":"65","author":"Eladl","year":"2015","journal-title":"Pathol. Int."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Sattarzadeh, A., Visser, L., Rutgers, B., Diepstra, A., Berg, A.V.D., and Wu, R. (2016). Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17122127"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3324\/haematol.2018.203224","article-title":"JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell\/histiocyte-rich large B-cell lymphoma","volume":"104","author":"Schuhmacher","year":"2018","journal-title":"Haematology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1038\/s41375-020-0739-7","article-title":"Genomic characterization of diffuse large B-cell lymphoma transformation of nodular lymphocyte-predominant Hodgkin lymphoma","volume":"34","author":"Song","year":"2020","journal-title":"Leukemia"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2020006464","article-title":"Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell\/histiocyte-rich large B-cell lymphoma","volume":"137","author":"Griffin","year":"2021","journal-title":"Blood"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/PAS.0b013e3181cc7e79","article-title":"PD-1 Expression in T-cell Lymphomas and Reactive Lymphoid Entities: Potential Overlap in Staining Patterns Between Lymphoma and Viral Lymphadenitis","volume":"34","author":"Krishnan","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin\u2019s Lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","article-title":"PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome","volume":"34","author":"Roemer","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","article-title":"Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion","volume":"3","author":"Wienand","year":"2019","journal-title":"Blood Adv."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/PAS.0b013e31822832de","article-title":"Nodular Lymphocyte-Predominant Hodgkin Lymphoma With Atypical T Cells","volume":"35","author":"Sohani","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1309\/AJCPFJWKQ6GTVQE6","article-title":"Large B-Cell Lymphomas Poor in B Cells and Rich in PD-1+ T Cells Can Mimic T-Cell Lymphomas","volume":"142","author":"Ohgami","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.humpath.2014.09.009","article-title":"Large B-cell lymphoma with T-cell\u2013rich background and nodules lacking follicular dendritic cell meshworks: Description of an insufficiently recognized variant","volume":"46","author":"Treetipsatit","year":"2015","journal-title":"Hum. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ajcp\/93.2.219","article-title":"Progressive Transformation of Germinal Centers With and Without Association to Hodgkin\u2019s Disease","volume":"93","author":"Hansmann","year":"1990","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1182\/blood.V97.3.714","article-title":"B-cell development in progressively transformed germinal centers: Similarities and differences compared with classical germinal centers and lymphocyte-predominant Hodgkin disease","volume":"97","author":"Yang","year":"2001","journal-title":"Blood"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.humpath.2015.07.006","article-title":"Immunoarchitectural patterns of progressive transformation of germinal centers with and without nodular lymphocyte-predominant Hodgkin lymphoma","volume":"46","author":"Hartmann","year":"2015","journal-title":"Hum. Pathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/cncy.22286","article-title":"Role of FNA with core biopsy or cell block in patients with nodular lymphocyte-predominant Hodgkin lymphoma","volume":"128","author":"Gupta","year":"2020","journal-title":"Cancer Cytopathol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Paschold, L., Willscher, E., Bein, J., Vornanen, M., Eichenauer, D.A., Simnica, D., Thiele, B., Wickenhauser, C., Rosenwald, A., and Bernd, H.-W. (2021). Evolutionary clonal trajectories in nodular lymphocyte predominant Hodgkin lymphoma with high transformation risk. Haematology, 22.","DOI":"10.3324\/haematol.2021.278427"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nm.3488","article-title":"Multiplexed ion beam imaging of human breast tumors","volume":"20","author":"Angelo","year":"2014","journal-title":"Nat. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2018.07.010","article-title":"Deep Profiling of Mouse Splenic Architecture with CODEX Multiplexed Imaging","volume":"174","author":"Goltsev","year":"2018","journal-title":"Cell"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"101562","DOI":"10.1016\/j.isci.2020.101562","article-title":"A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell Lymphomas","volume":"23","author":"Tripodo","year":"2020","journal-title":"iScience"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"103055","DOI":"10.1016\/j.ebiom.2020.103055","article-title":"Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces","volume":"61","author":"Sangaletti","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1080\/10428194.2020.1713319","article-title":"Metabolic tumor volume, cancer cell fraction, and prognosis\u2014The case of T-cell\/histiocyte-rich large B-cell lymphoma","volume":"61","author":"Schmitz","year":"2020","journal-title":"Leuk. Lymphoma"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/ajh.25972","article-title":"Lymphocyte predominant cells of nodular lymphocyte predominant Hodgkin lymphoma interact with rosetting T cells in an immunological synapse","volume":"95","author":"Bein","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1200\/JCO.2012.43.5958","article-title":"High Familial Risk in Nodular Lymphocyte-Predominant Hodgkin Lymphoma","volume":"31","author":"Saarinen","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1182\/blood-2011-03-341560","article-title":"Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma","volume":"118","author":"Saarinen","year":"2011","journal-title":"Blood"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Lorenzi, L., Tabellini, G., Vermi, W., Moratto, D., Porta, F., Notarangelo, L.D., Patrizi, O., Sozzani, S., Basile, G.D.S., and Latour, S. (2013). Occurrence of Nodular Lymphocyte-Predominant Hodgkin Lymphoma in Hermansky-Pudlak Type 2 Syndrome Is Associated to Natural Killer and Natural Killer T Cell Defects. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080131"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1097\/MPH.0000000000000948","article-title":"Nodular Lymphocyte-predominant Hodgkin Lymphoma in a 15-Year-Old Boy With Li-Fraumeni Syndrome Having a Germline TP53 D49H Mutation","volume":"40","author":"Yamazaki","year":"2018","journal-title":"J. Pediatr. Hematol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/s41467-019-09198-7","article-title":"Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans","volume":"10","author":"Kaasinen","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1182\/blood.V99.4.1492","article-title":"Germline FAS gene mutation in a case of ALPS and NLP Hodgkin lymphoma","volume":"99","author":"Berg","year":"2002","journal-title":"Blood"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/12\/3021\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:17:05Z","timestamp":1760163425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/12\/3021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":90,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["cancers13123021"],"URL":"https:\/\/doi.org\/10.3390\/cancers13123021","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]}}}